Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
indomethacin (indocin) (2 trials)
Prostatic Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (1 total)